Inside the High-Stakes Corporate Fight Over Feeding Preterm Babies
In 2013, a scientist at Abbott Laboratories saw study results with potentially big implications for…
Inside the High-Stakes Corporate Fight Over Feeding Preterm Babies
In 2013, a scientist at Abbott Laboratories saw study results with potentially big implications for the company’s profits and the lives of some of the world’s most fragile people: preterm infants. The upshot, she wrote in an email: Babies fed rival Mead Johnson Nutrition’s acidified liquid human milk fortifier — a nutritional supplement used in…
She Owed Her Insurer a Nickel, So It Canceled Her Coverage
Last summer, Lorena Alvarado Hill received a series of unexpected medical bills. A teacher’s aide in Melbourne, Florida, Hill is a single mom who works shifts at J.Crew on the weekends to send her daughter to college. Hill and her mother, who lives with her, had been enrolled in an insurance plan through HealthFirst. Hill…
Adventures in health care billing. My $51.96 zit co-insurance
By MATTHEW HOLT I know my many fans love me delving into the world of why we get seemingly incorrect trivial bills in health care, and what they all mean. The long telenovella of the $39.94 bill from Labcorp is as yet stalled with One Medical apparently resubmitting the original claim with the new preventative…
Everlywell, Jona Team Up to Expand Access to Gut Microbiome Test
Through a new partnership, consumers nationwide can access Jona’s gut microbiome test on Everlywell’s platform. The post Everlywell, Jona Team Up to Expand Access to Gut Microbiome Test appeared first on MedCity News.
FDA Approval Makes Rocket Pharma Gene Therapy the First for Ultra-Rare Immune Disorder
Rocket Pharmaceuticals received FDA approval for Kresladi, a gene therapy developed to treat leukocyte-adhesion deficiency type 1, an inherited immunodeficiency that can become fatal to infants and young children. Kresladi is the first gene therapy for this ultra-rare disease and the first commercial product for Rocket. The post FDA Approval Makes Rocket Pharma Gene Therapy…
How Are Health Systems Assessing ROI for AI Tools?
Michael Meucci, CEO of health data platform Arcadia, thinks health systems are changing their thinking about ROI when it comes to AI projects. As providers face tighter budgets, he said they’re broadening how they measure AI’s ROI, including benefits like reducing clinician burnout. The post How Are Health Systems Assessing ROI for AI Tools? appeared…
Scaling Autonomous AI in Healthcare Without Compromising Clinical Trust
AI in healthcare will not fail because the models are weak. It will stall when leaders hesitate to redesign how decisions are made, measured and governed. The post Scaling Autonomous AI in Healthcare Without Compromising Clinical Trust appeared first on MedCity News.
The Cost Blind Spot: Why Non-Clinical Spend Is Healthcare’s Untapped Opportunity
Providers that embrace benchmarks from outside of healthcare and move toward improved non-clinical spend management will unlock the resilience, innovation, and possibilities needed to stay strong in the years ahead. The post The Cost Blind Spot: Why Non-Clinical Spend Is Healthcare’s Untapped Opportunity appeared first on MedCity News.
AI Can Expand Access to Healthcare — But Only With Human Action
Health systems can turn insights into action, ensuring that preventive care actually happens by combining accurate risk prediction with human outreach and careful planning. The post AI Can Expand Access to Healthcare — But Only With Human Action appeared first on MedCity News.
HIV Symptoms in Women Early Signs Causes Testing Prevention
HIV Symptoms in Women: Early Warning Signs, Causes, Testing, and Prevention Table of Contents National Women and Girls HIV/AIDS Awareness Day National Women and Girls HIV/AIDS Awareness Day takes place on March 10. The main goal of the day is to raise awareness about HIV symptoms in women, highlight the significance of HIV testing, and…
